Turmeric Extract Supplementation Reduces Tau Protein Level in Repetitive Traumatic Brain Injury Model
DOI:
https://doi.org/10.3889/oamjms.2018.440Keywords:
repetitive traumatic brain injury, Turmeric extract, tau proteinAbstract
BACKGROUND: Repetitive traumatic brain injury (RTBI) has gained much attention in this decade, especially in contact sports athletes and military personals. This injury is correlated with early neurodegenerative changes that are marked with the increased of tau protein. Turmeric extract (TE) is a well-known anti-inflammation and antioxidant that decreases tau protein expression in neurodegenerative disease.
AIM: This study aimed to prove the effect of TE on tau protein level after RTBI.
METHODS: Forty Sprague Dawley mice were divided into four groups, i.e. negative sham control group, the control group, and two treatment groups. A weight drop model was used by applying a 40-gram mass that was dropped from a 1-meter height onto the vertex of the head, with a total frequency of 12 times, divided into 4 days (day 0, 1, 3, and 7; 3 traumas on each day). TE was given to all treatment groups with 500 mg/kg BW doses once daily. The first treatment group had TE for seven days along the trauma. The second treatment group had pretreatment TE extract, given from seven days before first trauma and continued along the trauma protocol days. Tau protein level was measured on brain and serum using ELISA method.
RESULTS: There was a significant reduction of tau protein level in both treatment groups compared to trauma group, either in serum or brain, but we also found significant differences regarding brain tau level between the treatment and pretreatment group.
CONCLUSION: This study might provide evidence of with the role of pretreatment TE in RTBI.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Hawkes N. Professional football may be linked to brain injuries usually seen in boxing. 2017: j811.
Peskind ER, Brody D, Cernak I, McKee A, Ruff RL. Military- and sports-related mild traumatic brain injury: clinical presentation, management, and long-term consequences. J Clin Psychiatry. 2013; 74(2):180–8–quiz188.
Giza CC, Hovda DA. The New Neurometabolic Cascade of Concussion. Neurosurgery. 2014; 75:S24–S33. https://doi.org/10.1227/NEU.0000000000000505 PMid:25232881 PMCid:PMC4479139
Vagnozzi R, Signoretti S, Cristofori L, Alessandrini F, Floris R, Isgro E, et al. Assessment of metabolic brain damage and recovery following mild traumatic brain injury: a multicentre, proton magnetic resonance spectroscopic study in concussed patients. Brain. 2010; 133(11):3232–42. https://doi.org/10.1093/brain/awq200 PMid:20736189
Longhi L, Saatman KE, Fujimoto S, Raghupathi R, Meaney DF, Davis J, et al. Temporal Window of Vulnerability to Repetitive Experimental Concussive Brain Injury. Neurosurgery. 2005; 56(2):364–74. https://doi.org/10.1227/01.NEU.0000149008.73513.44 PMid:15670384
Montenigro PH, Baugh CM, Daneshvar DH, Mez J, Budson AE, Au R, et al. Clinical subtypes of chronic traumatic encephalopathy: literature review and proposed research diagnostic criteria for traumatic encephalopathy syndrome. Alz Res Therapy. 2014; 6(5-8):709–17. https://doi.org/10.1186/s13195-014-0068-z PMid:25580160 PMCid:PMC4288217
McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Keene CD, Litvan I, et al. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol. 2017; 131(1):75–86. https://doi.org/10.1007/s00401-015-1515-z PMid:26667418 PMCid:PMC4698281
Cowan CM, Mudher A. Are tau aggregates toxic or protective in tauopathies? Front Neurol. 2013; 4:114. https://doi.org/10.3389/fneur.2013.00114 PMid:23964266 PMCid:PMC3741634
Schmidt ML, Zhukareva V, Newell KL, Lee VM, Trojanowski JQ. Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease. Acta Neuropathol. 2001; 101(5):518–24. PMid:11484824
McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE, et al. Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy After Repetitive Head Injury. Journal of Neuropathology & Experimental Neurology. 2009; 68(7):709–35. https://doi.org/10.1097/NEN.0b013e3181a9d503 PMid:19535999 PMCid:PMC2945234
Cherry JD, Tripodis Y, Alvarez VE, Huber B, Kiernan PT, Daneshvar DH, Mez J, Montenigro PH, Solomon TM, Alosco ML, Stern RA. Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy. Acta neuropathologica communications. 2016; 4(1):112. https://doi.org/10.1186/s40478-016-0382-8 PMid:27793189 PMCid:PMC5084333
van den Bedem H, Kuhl E. Molecular mechanisms of chronic traumatic encephalopathy. Current Opinion in Biomedical Engineering. 2017; 1:23-30. https://doi.org/10.1016/j.cobme.2017.02.003
Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. British Journal of Pharmacology. 2013; 169(8):1–21. PMid:23072488 PMCid:PMC3632233
Darvesh AS, Carroll RT, Bishayee A, Novotny NA, Geldenhuys WJ, Van der Schyf CJ. Curcumin and neurodegenerative diseases: a perspective. Expert Opinion on Investigational Drugs. 2012; 21(8):1123–40. https://doi.org/10.1517/13543784.2012.693479 PMid:22668065
Hamaguchi T, Ono K, Yamada M. REVIEW: Curcumin and Alzheimer's Disease. CNS Neuroscience & Therapeutics. 2010; 16(5):285–97. https://doi.org/10.1111/j.1755-5949.2010.00147.x PMid:20406252
Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of Curcumin: Problems and Promises. Mol Pharmaceutics. 2007; 4(6):807–18. https://doi.org/10.1021/mp700113r PMid:17999464
Xu L, Nguyen JV, Lehar M, Menon A, Rha E, Arena J, et al. Repetitive mild traumatic brain injury with impact acceleration in the mouse: Multifocal axonopathy, neuroinflammation, and neurodegeneration in the visual system. Experimental Neurology. 2016; 275(Part 3):436–49. https://doi.org/10.1016/j.expneurol.2014.11.004 PMid:25450468
Samini F, Samarghandian S, Borji A, Mohammadi G, bakaian M. Curcumin pretreatment attenuates brain lesion size and improves neurological function following traumatic brain injury in the rat. Pharmacology, Biochemistry and Behavior. 2013; 110(C):238–44. https://doi.org/10.1016/j.pbb.2013.07.019 PMid:23932920
McKee AC, Alosco ML, Huber BR. Repetitive Head Impacts and Chronic Traumatic Encephalopathy. Neurosurg Clin N Am. 2016; 27(4):529–35. https://doi.org/10.1016/j.nec.2016.05.009 PMid:27637402 PMCid:PMC5028120
Ojo J-O, Mouzon B, Greenberg MB, Bachmeier C, Mullan M, Crawford F. Repetitive mild traumatic brain injury augments tau pathology and glial activation in aged hTau mice. Journal of Neuropathology & Experimental Neurology. 2013; 72(2):137–51. https://doi.org/10.1097/NEN.0b013e3182814cdf PMid:23334597
Scheltens P, Blennow K, Breteler MMB, de Strooper B, Frisoni GB, Salloway S, et al. Alzheimer's disease. Lancet. 2016; 388(10043):505–17. https://doi.org/10.1016/S0140-6736(15)01124-1
Marklund N, Blennow K, Zetterberg H, Ronne-Engström E, Enblad P, Hillered L. Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury. Journal of Neurosurgery. 2009; 110(6):1227–37. https://doi.org/10.3171/2008.9.JNS08584 PMid:19216653
Franz G, Beer R, Kampfl A, Engelhardt K, Schmutzhard E, Ulmer H, et al. Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology. 2003; 60(9):1457–61. https://doi.org/10.1212/01.WNL.0000063313.57292.00 PMid:12743231
Olczak M, Niderla-Bielińska J, Kwiatkowska M, Samojłowicz D, Tarka S, Wierzba-Bobrowicz T. Tau protein (MAPT) as a possible biochemical marker of traumatic brain injury in postmortem examination. Forensic science international. 2017; 280:1-7. https://doi.org/10.1016/j.forsciint.2017.09.008 PMid:28942078
Neselius S, Zetterberg H, Blennow K, Randall J, Wilson D, Marcusson J, et al. Olympic boxing is associated with elevated levels of the neuronal protein tau in plasma. Brain Injury. 2013; 27(4):425–33. https://doi.org/10.3109/02699052.2012.750752 PMid:23473386
Ma M, Lindsell CJ, Rosenberry CM, Shaw GJ, Zemlan FP. Serum cleaved tau does not predict postconcussion syndrome after mild traumatic brain injury. The American Journal of Emergency Medicine. 2008; 26(7):763–8. https://doi.org/10.1016/j.ajem.2007.10.029 PMid:18774039 PMCid:PMC2576476
Papa L, Ramia MM, Edwards D, Johnson BD, Slobounov SM. Systematic Review of Clinical Studies Examining Biomarkers of Brain Injury in Athletes after Sports-Related Concussion. J Neurotrauma. 2015; 32(10):661–73. https://doi.org/10.1089/neu.2014.3655 PMid:25254425 PMCid:PMC4426313
Kane MJ, Angoa-Pérez M, Briggs DI, Viano DC, Kreipke CW, Kuhn DM. A mouse model of human repetitive mild traumatic brain injury. Journal of Neuroscience Methods. 2012; 203(1):41–9. https://doi.org/10.1016/j.jneumeth.2011.09.003 PMid:21930157 PMCid:PMC3221913
Ojo JO, Mouzon BC, Crawford F. Repetitive head trauma, chronic traumatic encephalopathy and tau: Challenges in translating from mice to men. Experimental Neurology. 2016; 275(Part 3):389–404. https://doi.org/10.1016/j.expneurol.2015.06.003 PMid:26054886
Chandra V, Pandav R, Dodge HH, Johnston JM, Belle SH, DeKosky ST, et al. Incidence of Alzheimer's disease in a rural community in India The Indo–US Study. Neurology. Lippincott Williams & Wilkins; 2001; 57(6):985–9. https://doi.org/10.1212/WNL.57.6.985
Ng TP, Chiam PC, Lee T, Chua HC, Lim L, Kua EH. Curry Consumption and Cognitive Function in the Elderly. American Journal of Epidemiology. 2006; 164(9):898–906. https://doi.org/10.1093/aje/kwj267 PMid:16870699
Gao Y, Li J, Wu L, Zhou C, Wang Q, Li X, Zhou M, Wang H. Tetrahydrocurcumin provides neuroprotection in rats after traumatic brain injury: autophagy and the PI3K/AKT pathways as a potential mechanism. Journal of surgical research. 2016; 206(1):67-76. https://doi.org/10.1016/j.jss.2016.07.014 PMid:27916377
Wang YL, Li JF, Wang YT, Xu CY, Hua LL, Yang XP, Geng S, Wang SS, Wang Z, Yin HL. Curcumin reduces hippocampal neuron apoptosis and JNK-3 phosphorylation in rats with Aβ-induced Alzheimer's disease: protecting spatial learning and memory. Journal of Neurorestoratology. 2017; 5:117-23. https://doi.org/10.2147/JN.S125567
Sun J, Zhang X, Wang C, Teng Z, Li Y. Curcumin Decreases Hyperphosphorylation of Tau by Down-Regulating Caveolin-1/GSK-3β in N2a/APP695swe Cells and APP/PS1 Double Transgenic Alzheimer's Disease Mice. Am J Chin Med. 2017; 45(08):1667–82. https://doi.org/10.1142/S0192415X17500902 PMid:29132216
Maiti P, Manna J, Veleri S, Frautschy S. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin. BioMed Research International. 2014; 2014(1):495091–14. https://doi.org/10.1155/2014/495091
Gao S, Zhou J, Liu N, Wang L, Gao Q, Wu Y, Zhao Q, Liu P, Wang S, Liu Y, Guo N. Curcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13. Journal of molecular and cellular cardiology. 2015; 85:131-9. https://doi.org/10.1016/j.yjmcc.2015.04.025 PMid:25944087
Simon DW, McGeachy MJ, Bayır H, Clark RSB, Loane DJ, Kochanek PM. The far-reaching scope of neuroinflammation after traumatic brain injury. Nature Reviews Neurology. 2017; 13(3):171–91. https://doi.org/10.1038/nrneurol.2017.13 PMid:28186177 PMCid:PMC5675525
González-Reyes S, Guzmán-Beltrán S, Medina-Campos ON, Pedraza-Chaverri J. Curcumin pretreatment induces Nrf2 and an antioxidant response and prevents hemin-induced toxicity in primary cultures of cerebellar granule neurons of rats. Oxidative Medicine and Cellular Longevity. Hindawi; 2013; 2013(22):801418–14.
Zetterberg H. Review: Tau in biofluids - relation to pathology, imaging and clinical features. Neuropathol Appl Neurobiol. 2017; 43(3):194–9. https://doi.org/10.1111/nan.12378 PMid:28054371
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Andre Marolop Pangihutan Siahaan, Iskandar Japardi, Aldy Rambe, Rr Suzy Indharty, Muhammad Ichwan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
